𝔖 Bobbio Scriptorium

✦ LIBER ✦

693 INTERIM ANALYSIS OF RANDOMIZED, CONTROLLED TRIAL COMPARING THYMOSIN ALPHA-1 PLUS PEGYLATED INTERFERON ALPHA-2A COMBINATION THERAPY WITH PEGYLATED INTERFERON ÁLPHA-2A MONOTHERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B

✍ Scribed by W. Kim; J.H. Yoon; Y.J. Lee; S.J. Park; B.H. Kim; J.H. Lee; J.I. Yang; S.J. Myung; D.H. Kim; Y.J. Kim; H.S. Lee

Book ID: 117376619
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 58 KB
Volume: 48
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(08)60695-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled trial with pegylated interfer

Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

✍ G. Teuber; B. Kallinowski; C. Niederau; H. Klinker; P.R. Galle; M. Zankel; S. Ze 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

457 Retreatment with pegylated interfero

457 Retreatment with pegylated interferon alpha-2B and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus REG

✍ C. Bapin; P. Fabbro-Peray; S. Hachemane; F. Blanc; D. Diaz; P. Pueyo; D. Larrey 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A 3-ARM randomized study evaluating the

A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis

✍ Alessandra Mangia; Giovanni Ricci; Nicola Minerva; Marcello Persico; Vito Carret 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Pegylated interferon alfa-2B plus ribavi

Pegylated interferon alfa-2B plus ribavirin in patients with chronic hepatitis C: a trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers: Ira M Jacobson, Mark W Russo, Weill Medical College of Cornell University, New York, NY; Robert S Brown, Columbia College of Physicians and Surgeons, New York, NY; Edward Lebovics, New York Medical College, Valhalla, NY; Albert Min, Mount Sinai, New York, NY; Stephen Esposito, NYH-Queens, Flushing, NY; Hillel Tobias, NYU Med Ctr, New York, NY; Frank Klion, Mount Sinai, New York, NY; Olga Pizov, Weill Medical College of Cornell University, New York, NY; Cliff Brass, Schering-Plough, Kenilworth, NJ; NY PEG-Intron Study Group, New York, NY

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB